Background and Aim: Repeated water avoidance stress (WAS) induces visceral hypersensitivity. Additionally, it is also known to activate corticotropin-releasing factor (CRF), mast cells, and pro-inflammatory cytokines systems, but their precise roles on visceral sensation have not been determined definitely. The aim of the study was to explore this issue. Methods: Abdominal muscle contractions induced by colonic balloon distention, that is, visceromotor response (VMR) was detected electrophysiologically in conscious rats. WAS or sham stress as control for 1 h daily was loaded, and the threshold of VMR was determined before and at 24 h after the stress. Results: Repeated WAS for three consecutive days reduced the threshold of VMR, but sham stress did not induce any change. Astressin, a CRF receptor antagonist (50 μg/kg) intraperitoneally (ip) at 10 min before each WAS session, prevented the visceral allodynia, but the antagonist (200 μg/kg) ip at 30 min and 15 h before measurement of the threshold after completing 3-day stress session did not modify the response. Ketotifen, a mast cell stabilizer (3 mg/kg), anakinra, an interleukin (IL)-1 receptor antagonist (20 mg/kg) or IL-6 antibody (16.6 μg/kg) ip for two times before the measurement abolished the response. Conclusions: Repeated WAS for three consecutive days induced visceral allodynia, which was mediated through mast cells, IL-1, and IL-6 pathways. Inhibition of peripheral CRF signaling prevented but did not reverse this response, suggesting that peripheral CRF may be an essential trigger but may not contribute to the maintenance of repeated WAS-induced visceral allodynia.
Introduction
Irritable bowel syndrome (IBS) is one of the functional gastrointestinal (GI) disorders characterized by the presence of recurrent abdominal pain with altered bowel habits without any organic cause. 1 Stress induces onset and/or exaggeration of GI symptoms in the majority of IBS patients. 2 The pathophysiology has not been completely defined, but disturbed gut motility and altered visceral sensory function play an important role at least in part. 3 Because stress alters GI motility and visceral sensation through central and peripheral corticotropin-releasing factor (CRF), CRF-mediated GI responses are thought to be involved in IBS pathophysiology. 3, 4 The actions of CRF are mediated through the activation of two receptors, CRF receptor type 1 (CRF 1 ) and type 2 (CRF 2 ), 5 and activation of each CRF receptor induces distinct responses in GI tract, that is, stimulation of colonic motility and inducing visceral hypersensitivity to colorectal distension (CRD) by CRF 1 , and delayed gastric emptying by CRF 2 exclusively. 3, 4, 6 Water avoidance stress (WAS) is a conventional psychological stress protocol, and several studies reported that repeated WAS induced visceral hyperalgesia in rodents. [7] [8] [9] [10] Because accumulation of continuous life stress (chronic stress) often causes the exacerbation of symptoms in IBS, 11 chronic repeated WAS is thought to be an appropriate animal stress model of IBS. 12 Although WAS is well known to activate CRF signaling 13 and increase the expression of pro-inflammatory cytokines in GI tract, 7, 8 their roles on visceral hypersensitivity have not been determined definitely and directly.
We have very recently shown that lipopolysaccharide (LPS)-induced visceral allodynia was mediated through peripheral CRF, interleukin (IL)-1, and IL-6 in rats. 14 Incidentally, several investigators reported that circulatory LPS and pro-inflammatory cytokines were increased in IBS 15, 16 and suggested that LPScytokines system may be involved in the visceral hypersensitivity observed in IBS. 17 In this context, LPS-induced visceral hypersensitivity is thought to simulate the pathophysiology of IBS. Then, we hypothesized that repeated WAS-induced visceral hypersensitivity is mediated through common pathways to LPS, that is, peripheral CRF, IL-1, and IL-6.
In the present study, we established the rat model of visceral hypersensitivity induced by repeated WAS, and the roles of peripheral CRF signaling, IL-1, and IL-6 were determined in this model. Additionally, because LPS or WAS was also reported to activate mast cells, 18 the role was also explored.
Materials and methods
Animals. Adult male Sprague-Dawley rats (Charles River Laboratory, Atsugi, Japan) weighing about 300 g were housed grouply (three to four rats/cage) under controlled conditions of illumination (12 h light/dark cycle starting at 7 AM) and temperature at 23-25°C with food (Solid rat chow, Oriental Yeast, Tokyo, Japan) and water available ad libitum.
Chemicals. Astressin (Sigma-Aldrich, St. Louis, MO, USA), a non-selective CRF 1 and CRF 2 receptor antagonist, was dissolved in double-distilled water. Anakinra (Swedish Orphan Biovitrum, Stockholm, Sweden), an IL-1 receptor antagonist, and ketotifen (Sigma-Aldrich), a connective tissue mast cell stabilizer, were dissolved in normal saline. Goat anti-rat IL-6-neutralizing antibody and normal goat IgG (R&D Systems, Minneapolis, MN, USA) were dissolved in sterile phosphatebuffered saline. The doses of the chemicals were determined according to the previous reports. 14, 19 The volume of injection was 0.2 mL/rat.
Measurement of visceral sensation. Visceral sensation was assessed by abdominal muscle contractions induced by colonic distention (visceromotor response; VMR) using electromyogram (EMG) in conscious rats, which was validated as quantitative measure of visceral nociception. 20 Implantation of electrodes and placement of colonic distention balloon. Under brief ether anesthesia, a small skin incision about 5 mm in length was made in non-fasted rats, and electrodes (Teflon-coated stainless steel, 0.05-mm diameter, MT Giken, Tokyo, Japan) for EMG were inserted approximately 2 mm into the left side external oblique musculature through the incision. They were fixed to musculature, and the incised skin was closed by cyanoacrylate instant adhesive (Aron Alpha, TOAGOSEI, Tokyo, Japan). The electrode leads were externalized directly through this closed incision without subcutaneous tunnel and threaded through a urethane tube. Distension balloon (6-Fr disposable silicon balloon-urethral catheter, JU-SB0601, Terumo Corporation, Tokyo, Japan) was inserted intra-anally with the distal end positioned 2 cm proximal to the anus. The volume and length of maximally inflated balloon was 1.5 mL and 1.2 cm, respectively.
Colonic distention and measuring abdominal muscle contractions. After completing the surgery for the electrodes implantation and balloon placement, the rats were placed in Bollmann cages and allowed to recover from the anesthesia, and acclimated to the experimental condition for 30 min before testing. The animals were trained to the experimental conditions by placing them singly in Bollmann cages for 1 h before the day of experiment. Later, electrode leads were connected to an EMG amplifier, and EMG signals were amplified, filtered (3000 Hz), digitized by a PowerLab system (AD Instruments, Colorado Springs, CO, USA), and recorded using computer software (LabChart 7, AD Instruments). Colonic distension was performed at 30 min after the surgery according to a previous publication, 14 namely, ascending method of limits phasic distension was applied in increments of 0.1 mL for 5 s by inflating the balloon by water using a syringe manually until significant abdominal muscle contractions, that is, VMR, were detected. The threshold of VMR was defined as the distended balloon volume (mL) inducing VMR (Fig. 1a) . Tang et al. 21 previously demonstrated that the pain threshold induced by CRD assessed by the observation of abdominal withdrawal reflex using the balloon quite similar to ours could be determined as distended balloon volume in rats and also showed that intracolonic pressure was linearly associated with intraballoon volume. The threshold was assessed two times (2 min interval), and the mean of the threshold was calculated as the data of the animals.
Stress protocol. Exposure to WAS was performed as described previously. 22 Rats were placed individually on a plastic platform (height, 8 cm; length, 6 cm; width, 6 cm) positioned in the middle of a plastic cage filled with water up to 7 cm of the height of the platform. To avoid contact with water, rats stood on a platform during the entire stress period. Control animals were also put on the same plastic platform in a plastic cage but not filled with water (sham stress).
Experimental procedures. The non-fasted rats were submitted to colonic balloon distention, and the basal threshold of VMR was measured. Then the electrodes and distention balloon were removed, and either WAS or sham stress (controls) for 1 h was applied. First, in order to establish the rat model of visceral hypersensitivity, we determined the time-course effect of repeated WAS from single session (Fig. 1b) . Each group of animals (n = 6-9) was loaded by different times of daily 1-h stress session, and the experiment continued until detecting significant visceral allodynia after repeated WAS. After completing each stress session, the animals were returned to their group housing cages. Stress sessions were performed at 8-12 AM After 24 h from the last stress session, the animals underwent surgery for the electrodes implantation and balloon placement and put in the Bollmann cages again. After 30 min, the threshold was determined.
Next, the mechanisms of repeated WAS-induced visceral hypersensitivity were explored using this established model. The effect of astressin, ketotifen, anakinra, and IL-6 antibody were tested. These drugs were administered at 30 min and 15 h before colonic distention performed after completing repeated WAS or sham stress session through intraperitoneal (ip) route (Fig. 1c) . In another series of experiment, astressin was also administered at 10 min before each stress session, repeatedly (Fig. 1d) .
Statistical analysis. Data were expressed as means ± SE. Multiple comparison was performed by two-way ANOVA followed by Fisher's least significant difference test. Comparison between two groups was performed using the Student's t-test or paired t-test. SYSTAT 13 software (Systat Software, Chicago, IL, USA) was used throughout the study. 
Results
Repeated daily water avoidance stress for three consecutive days induced visceral allodynia. Single and 2-day WAS session did not change the threshold of VMR at 24 h after the last WAS (Fig. 2a) . On the other hand, WAS for three consecutive days significantly reduced the threshold (mL) from 0.53 ± 0.020 to 0.36 ± 0.031 (P < 0.05). Sham stress did not alter it. Moreover, the % change threshold, that is, the value of the threshold after stress divided by the one of the basal threshold, multiplied by 100 was significantly reduced in 3-day WAS group as compared with sham stress one (67.2 ± 5.8 for WAS vs 97.8 ± 5.4 for sham stress, P < 0.05), but it was not changed in single or 2-day WAS group (Fig. 2b) . Because 3-day WAS was definitely demonstrated to induce visceral allodynia as described previously, the % change threshold was presented in the following experiments in order to assess the effect of drugs on this response.
Corticotropin-releasing factor receptor antagonist, astressin, prevented but did not reverse repeated water avoidance stress-induced visceral allodynia. Ip-repeated injections of astressin at 50 μg/kg before the each stress session prevented the allodynia without altering the threshold in sham stress group (effect of WAS: F = 6.0, P < 0.05; effect of astressin: F = 11.8, P < 0.05; interaction of WAS and astressin: F = 11.1, P < 0.05; 96.2 ± 7.0 for vehicle + sham vs 64.8 ± 4.9 for vehicle + WAS, P < 0.05; 101.7 ± 3.7 for astressin + WAS vs vehicle + WAS, P < 0.05; Fig. 3a) .
On the other hand, ip astressin at 200 μg/kg twice before measuring the threshold after completing 3-day stress session neither modified the response induced by repeated WAS nor the threshold in sham-stressed rats (effect of WAS: F = 40.7, P < 0.05; effect of astressin: F = 0.11, P > 0.05; interaction of WAS and astressin: F = 0.22, P > 0.05; Fig. 3b ). This dose of antagonist was known to block CRD-or LPS-induced visceral hypersensitivity in rats. 14, 23 Mast cell stabilizer, ketotifen, attenuated repeated water avoidance stress-induced visceral allodynia. Ketotifen at 3 mg/kg twice before measuring the threshold did not alter the threshold in sham-stressed rats but reversed the WAS-induced response (effect of WAS: F = 7.0, P < 0.05; effect of ketotifen: F = 11.2, P < 0.05; interaction of WAS and ketotifen: F = 4.5, P < 0.05; 94.1 ± 4.0 for sham + vehicle Schematic representation of experimental protocol. The surgery for EMG electrodes and balloon placement were performed, and 30 min later, basal VMR threshold was measured. Then the animals were submitted to1-h stress session such as water avoidance or sham stress. First, in order to establish the rat model of visceral hypersensitivity, different times of daily stress session were loaded to each group of animals until detecting significant visceral allodynia after repeated water avoidance stress (WAS). After 24 h from the last stress session, the animals underwent surgery again and the threshold was determined. (c) Next, the mechanisms of repeated WAS-induced visceral hypersensitivity were explored using this established model. Pharmacological intervention was performed at 30 min and 15 h before measurement of the threshold. (d) In another series of experiment, astressin was administered at 10 min before each stress session, repeatedly. , Surgery; , Measurement;
, Water avoidance or sham stress; Astressin, ketotifen, anakinra, interleukin-6 antibody, or vehicle injection; , Astressin or vehicle injection.
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vs 68.1 ± 5.0 for WAS + vehicle, P < 0.05; 92.3 ± 7.0 for WAS + ketotifen vs WAS + vehicle, P < 0.05; Fig. 4 ).
Interleukin-1 receptor antagonist, anakinra reversed repeated water avoidance stress-induced visceral allodynia. The administration of anakinra at 20 mg/kg twice before measuring the threshold blocked the allodynia, but the antagonist did not change the threshold in sham stress group (effect of WAS: F = 14.4, P < 0.05; effect of anakinra: F = 11.2, P < 0.05; interaction of WAS and anakinra: F = 6.0, P < 0.05; 95.7 ± 2.9 for sham + vehicle vs 66.3 ± 4.5 for WAS + vehicle, P < 0.05; 93.6 ± 5.5 for WAS + anakinra vs WAS + vehicle, P < 0.05; Fig. 5 ).
Interleukin-6 antibody blocked repeated water avoidance stress-induced visceral allodynia. Interleukin-6 antibody at 16.6 μg/kg injected twice before measuring the threshold also abolished the response by repeated WAS without affecting the threshold in sham stress group (effect of WAS: F = 5.3, P < 0.05; effect of IL-6 antibody: F = 5.8, P < 0.05; interaction of WAS and IL-6 antibody: F = 17.0, P < 0.05; 107.1 ± 7.4 for sham + vehicle vs 70.0 ± 3.8 for Figure 2 (a) Effect of repeated water avoidance stress (WAS) on the threshold of visceromotor response (VMR) induced by colonic distention. One-or 2-day WAS did not alter the threshold, but 3-day WAS significantly reduced it. Sham stress did not modify the threshold. *P < 0.05 versus basal threshold by paired t-test. (b) Percentage change threshold was significantly reduced in 3-day WAS group as compared with sham stress group. There was no significant difference between 1-and 2-day WAS and respective control group. *P < 0.05 versus Sham by Student's t-test. Each column represents the mean ± SE. Number of rats examined is shown in the parenthesis. Sham, sham stress. , Basal; , After stress. Figure 3 The effect of astressin on repeated water avoidance stress (WAS)-induced visceral allodynia. (a) Astressin (50 μg/kg) injected 10 min before each stress session prevented WAS-induced allodynia without altering the threshold in sham-stressed rats. *P < 0.05 versus Vehicle + Sham, #P < 0.05 versus Vehicle + WAS by two-way ANOVA followed by Fisher's least significant difference test. (b) Astressin (200 μg/kg) injected twice before the measurement of threshold after completing the 3-day stress session neither modify the response induced by WAS nor the threshold in sham-stressed rats. *P < 0.05 versus Sham + Vehicle by two-way ANOVA followed by Fisher's least significant difference test. Each column represents the mean ± SE. Number of rats examined is shown in the parenthesis. Sham, sham stress.
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Stress and visceral hypersensitivity WAS + vehicle, P < 0.05; 107.8 ± 7.2 for WAS + IL-6 antibody vs WAS + vehicle, P < 0.05; Fig. 6 ).
Discussion
There are several studies investigating the effects of repeated WAS on visceral sensation in rodents, and the majority of them demonstrated that repeated WAS induced visceral hypersensitivity. [7] [8] [9] [10] However, a few studies reported that it induced hyposensitivity or no change. 24, 25 The discrepancy of the results may be explained by the difference of animals, sex, or method measuring abdominal contractions induced by colonic distention, such as EMG and non-invasive manometry. 24, 26 Our method detected the threshold of VMR by EMG with acute preparation, and we showed previously that acute single WAS induced visceral hyposensitivity using this method. 27 In the current study, we showed that 3-day WAS induced visceral allodynia and tried to determine the roles of peripheral CRF, mast cells, IL-1, and IL-6, which were previously proved to mediate LPS-induced visceral allodynia. 14 Several studies showed that acute WAS activates both central and peripheral CRF signaling, which mediates altered GI motility and visceral sensation induced by WAS. 13, 27, 28 However, there were only few studies reporting the role of CRF signaling on chronic WAS-induced visceral hypersensitivity. Larauche et al. 10 showed that repeated WAS-induced visceral hyperalgesia was prevented by repeated peripheral injections of astressin before daily WAS session in rats. In the present study, the same result was obtained, which further suggests that the development of visceral hypersensitivity by chronic WAS may be mediated through peripheral CRF receptors, because astressin is peripherally restricted CRF receptor antagonist.
Incidentally, the current study also demonstrated the interesting result that the administration of astressin after 3-day WAS did not reverse the response by WAS. It implies that activating peripheral CRF signaling may be an essential trigger but may not contribute to the maintenance of repeated WAS-induced visceral allodynia. Figure 4 The effect of ketotifen on repeated water avoidance stress (WAS)-induced visceral allodynia. Ketotifen at 3 mg/kg twice after completing the 3-day stress session abolished the response induced by WAS without altering the threshold in sham-stressed rats. *P < 0.05 versus Sham + Vehicle, #P < 0.05 versus WAS + Vehicle by two-way ANOVA followed by Fisher's least significant difference test. Each column represents the mean ± SE. Number of rats examined is shown in the parenthesis. Sham, sham stress. Figure 5 The effect of anakinra on repeated water avoidance stress (WAS)-induced visceral allodynia. Anakinra at 20 mg/kg twice before measuring the threshold after stress sessions reversed WAS-induced allodynia without modifying the threshold in sham-stressed rats. *P < 0.05 versus Sham + Vehicle, #P < 0.05 versus WAS + Vehicle by two-way ANOVA followed by Fisher's least significant difference test. Each column represents the mean ± SE. Number of rats examined is shown in the parenthesis. Sham, sham stress. Figure 6 Interleukin (IL)-6 antibody (ab) at 16.6 μg/kg injected twice before measuring the threshold blocked repeated water avoidance stress (WAS)-induced allodynia. However, IL-6 ab per se did not alter the threshold. *P < 0.05 versus Sham + Vehicle, #P < 0.05 versus WAS + Vehicle by two-way ANOVA followed by Fisher's least significant difference test. Each column represents the mean ± SE. Number of rats examined is shown in the parenthesis. Sham, sham stress.
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Activating peripheral CRF/CRF 1 induces visceral hyperalgesia, 29 and acute stress such as CRD-induced visceral hyperalgesia was abolished by the peripheral administration of astressin. 23 On the other hand, we previously demonstrated that peripheral activation of CRF 1 did not induce visceral allodynia in the similar experimental settings to the current study. 14 Together with the results that astressin prevented but did not reverse the allodynia, these lines of evidence suggest that peripheral CRF/CRF 1 may directly contribute to the visceral hypersensitivity induced by acute stress as opposed to chronic repeated WAS. Therefore, we hypothesized that peripheral CRF signaling activated by repeated WAS triggers to activate other systems, thereby inducing visceral allodynia, but does not directly contribute to the response.
Mast cells have CRF receptors at their surface, 30 and acute stress evokes mast cells degranulation to release a large variety of mediators such as serotonin and prostaglandins, which is triggered by peripheral CRF in GI tract. 31 These mediators were demonstrated to activate visceral afferents, 32 leading to induction of visceral sensitization. 28 Additionally, chronic WAS is also known to increase and activate mast cells, 7, 18 and mast cells degranulation directly contributes to WAS-induced visceral hypersensitivity in maternally separated rats. 33 The result of that ketotifen abolished the allodynia by WAS in the present study is consistent with the evidence earlier. In addition, we also confirmed that ketotifen abolished LPS-induced allodynia (data were not shown), indicating that activation of mast cells may be one of the common pathways mediating visceral hypersensitivity by chronic WAS and LPS.
Chronic WAS is well demonstrated to increase proinflammatory cytokines in both gene and protein level in the GI tract. 7, 8, 34 However, it has not been shown that these cytokines are directly involved in WAS-induced visceral hypersensitivity so far. We believed that this is the first report showing the direct link between the cytokines and chronic WAS-induced visceral hypersensitivity, because anakinra or IL-6 antibody abolished the response.
Inteleukin-1 receptors are proved to be located in the neurons in rat dorsal root ganglia. 35 IL-6-receptor complex binds to the transmembrane signal-transducing subunit, glycoprotein 130, which is also expressed in dorsal root ganglia neurons. 36 Thus, these cytokines possibly evoke visceral hypersensitivity through directly activating sensory afferents through these receptors.
The link between peripheral CRF and the pro-inflammatory cytokines on modulating visceral sensation has been also suggested. Repeated WAS increases gut permeability through peripheral CRF receptors, and exogenous CRF administration mimics this response. 37 Increased permeability leads to an increase in bacterial translocation resulting in activating local immune system and inflammation, thereby increasing the release of LPS and the cytokines. 38 CRF potentiates the response of macrophages to LPS, that is, enhancing the synthesis of the pro-inflammatory cytokines through CRF 1 . 39 Additionally, we have very recently shown that IL-1β-induced allodynia was not blocked by ip astressin, 14 suggesting that IL-1 system may be more downstream signaling to modulate the visceral sensation as compared with CRF on WAS-induced allodynia. In this context, in addition to mast cells, these cytokines pathways might also be one of the systems, which CRF signaling modulates to develop visceral allodynia. These scenarios may also explain the similarity of the pathways mediating the visceral sensory response by chronic WAS and LPS.
We did not demonstrate the direct link between CRF and the cytokines. Besides, various cells other than macrophage or monocyte, such as fibroblasts, endothelial, neuronal, and smooth muscle cells, 40, 41 secrete our tested cytokines, but the sources responsible for the allodynia were not determined. These are the limitations of our study. Because other cytokines such as TNF-α and IL-8 have been suggested to be associated with the pathogenesis of IBS, 42 the role of these cytokines should be also evaluated in the future.
Growing evidence supports that peripheral immune mechanisms could contribute to the IBS pathophysiology. 42, 43 Some IBS patients exhibit low-grade gut mucosal inflammation with activated mast cells and enhanced expression of pro-inflammatory cytokines with increased serum LPS, resulting in abnormal neural responses, leading to altered colonic functions. 3, 15, 44 In this context, we previously proposed that LPS-induced visceral allodynia is the rat model of IBS.
14 Present study definitely showed that WAS activated mast cells, pro-inflammatory cytokines, and peripheral CRF systems, which contributed to chronic psychological stress-induced visceral hypersensitivity. These systems are common pathways inducing visceral allodynia by LPS and WAS, speculating that the link between brain and immune system via peripheral CRF may play a crucial role in the pathophysiology of IBS.
In summary, we demonstrated that repeated WAS for three consecutive days induced visceral allodynia, which was mediated through mast cells, IL-1, and IL-6 pathways. Inhibition of peripheral CRF signaling prevented but did not reverse this response, suggesting that peripheral CRF may be an essential trigger but may not contribute to the maintenance of repeated WAS-induced visceral allodynia. These results further suggest the crucial contribution of CRF, mast cells, and cytokines systems to the pathophysiology of IBS.
